C H Marquette
Overview
Explore the profile of C H Marquette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benzaquen J, Pradelli J, Padovani B, Marquette C, Leroy S
Rev Mal Respir
. 2018 Feb;
35(1):83-87.
PMID: 29402641
Introduction: Chronic obstructive pulmonary disease (COPD) is a common condition that may initially look simple but may conceal other diseases capable of accelerating its natural history or even simulating it....
2.
Ilie M, Long-Mira E, Bence C, Butori C, Lassalle S, Bouhlel L, et al.
Ann Oncol
. 2015 Oct;
27(1):147-53.
PMID: 26483045
Background: High expression of programmed death ligand-1 (PD-L1) on tumor cells (TC) and/or on tumor-infiltrating immune cells (IC) is associated with a high response rate in patients with advanced nonsmall-cell...
3.
Guibert N, Ilie M, Long E, Hofman V, Bouhlel L, Brest P, et al.
Curr Mol Med
. 2015 May;
15(5):418-32.
PMID: 25941815
KRAS mutations are detected in over one third of lung adenocarcinomas, most frequently in Caucasian and smoker patients. The impact of KRAS mutations on lung adenocarcinoma prognosis is currently subject...
4.
Ilie M, Bence C, Hofman V, Long-Mira E, Butori C, Bouhlel L, et al.
Ann Oncol
. 2014 Oct;
26(1):238-244.
PMID: 25344360
Background: Patients with advanced lung adenocarcinomas expressing ALK rearrangements are highly responsive to crizotinib, a dual ALK/c-MET inhibitor. Immunohistochemistry (IHC) is an easy clinically and routinely applicable cost-effective assay for...
5.
Baque-Juston M, Pellegrin A, Leroy S, Marquette C, Padovani B
Diagn Interv Imaging
. 2014 Feb;
95(9):771-7.
PMID: 24559802
Organizing pneumonia (formerly named bronchiolitis obliterans with organizing pneumonia or BOOP) is a clinical, radiological and histological entity that is classified as an Interstitial Lung Disease. The understanding of this...
6.
Ilie M, Long E, Hofman V, Dadone B, Marquette C, Mouroux J, et al.
Ann Oncol
. 2012 Nov;
24(3):742-8.
PMID: 23131393
Background: Non-small-cell lung carcinoma (NSCLC) patients with a BRAF(V600E) mutation benefit from targeted therapy. The usefulness of immunohistochemistry (IHC) as an alternative approach for the detection of BRAF(V600E) in NSCLC...
7.
Ilie M, Long E, Butori C, Hofman V, Coelle C, Mauro V, et al.
Ann Oncol
. 2012 Jun;
23(11):2907-2913.
PMID: 22735679
Background: A subgroup of anaplastic lymphoma kinase (ALK)-rearranged lung tumours can respond to ALK inhibitors. Until now, the ALK status in circulating tumour cells (CTCs) isolated from patients with lung...
8.
Martinez S, Sellam V, Marco S, Sanfiorenzo C, Macone F, Marquette C
Rev Mal Respir
. 2011 Feb;
28(1):92-6.
PMID: 21277482
Introduction: Modern immunosuppressive therapy may be responsible for toxic, immunologic and infectious pulmonary diseases. Case Report: We report the case of a 58-year old woman treated for rheumatoid arthritis who...
9.
Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud J, Flejou J, et al.
Cytopathology
. 2011 Jan;
23(1):30-8.
PMID: 21210876
Background And Objective: Recurrence rates after surgery for non-small cell lung cancer (NSCLC) range from 25 to 50% and 5-year survival is only 60-70%. Because no biomarkers are predictive of...
10.
Magro P, Garand G, Cattier B, Renjard L, Marquette C, Diot P
Rev Mal Respir
. 2007 Oct;
24(7):883-7.
PMID: 17925671
Introduction: We report a case of tracheobronchopathia osteochondroplastica associated with Ozena (atrophic rhinitis). Observation: Fibreoptic bonchoscopy showed irregular tracheal stenosis and histopathological examination displayed zones of bone metaplasia in the...